Patent ID: 6448003
Filing Date: 2002-09-10
Classification: C12Q

Abstract:
An isolated STP2 polynucleotide comprising a nucleic acid sequence selected from the group consisting of:(a) a nucleic acid sequence comprising at least 12 contiguous nucleotides of a nucleic acid sequence selected from the group consisting of SEQ ID NO:68, SEQ ID NO:70, SEQ ID NO:72, SEQ ID NO:74, SEQ ID NO:76, SEQ ID NO:77, SEQ ID NO:82, SEQ ID NO:84, SEQ ID NO:88, SEQ ID NO:96, SEQ D NO:97, SEQ ID NO:100, SEQ ID NO:102, SEQ ID NO:104, SEQ ID NO:108, and SEQ ID NO:109, (b) a nucleic acid sequence comprising at least 50 contiguous nucleotides and comprising a nucleic acid sequence selected from the group consisting of SEQ ID NO:80, and SEQ ID NO:106; (c) a nucleic acid sequence comprising at least 100 contiguous nucleotides and comprising a nucleic acid sequence of SEQ ID NO:102; and, (d) a nucleic acid sequence that is fully complementary to a nucleic acid sequence of (a), (b), or (c).